nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—G alpha (q) signalling events—MGLL—osteoporosis	0.00147	0.0617	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.00131	0.0552	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00113	0.0476	CbGpPWpGaD
Fosaprepitant—Cough—Zoledronate—osteoporosis	0.000984	0.00101	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Estradiol—osteoporosis	0.000981	0.001	CcSEcCtD
Fosaprepitant—Urethral disorder—Estradiol—osteoporosis	0.000978	0.001	CcSEcCtD
Fosaprepitant—Rash—Etidronic acid—osteoporosis	0.000977	0.001	CcSEcCtD
Fosaprepitant—Dermatitis—Etidronic acid—osteoporosis	0.000976	0.001	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Pamidronate—osteoporosis	0.000974	0.000997	CcSEcCtD
Fosaprepitant—Syncope—Conjugated Estrogens—osteoporosis	0.000973	0.000997	CcSEcCtD
Fosaprepitant—Hypertension—Zoledronate—osteoporosis	0.000973	0.000997	CcSEcCtD
Fosaprepitant—Hypersensitivity—Alendronate—osteoporosis	0.000973	0.000997	CcSEcCtD
Fosaprepitant—Headache—Etidronic acid—osteoporosis	0.000971	0.000994	CcSEcCtD
Fosaprepitant—Asthenia—Estropipate—osteoporosis	0.000962	0.000985	CcSEcCtD
Fosaprepitant—Chest pain—Zoledronate—osteoporosis	0.00096	0.000983	CcSEcCtD
Fosaprepitant—Palpitations—Conjugated Estrogens—osteoporosis	0.000959	0.000983	CcSEcCtD
Fosaprepitant—Insomnia—Risedronate—osteoporosis	0.000958	0.000982	CcSEcCtD
Fosaprepitant—Anxiety—Zoledronate—osteoporosis	0.000956	0.00098	CcSEcCtD
Fosaprepitant—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000954	0.000977	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000953	0.000976	CcSEcCtD
Fosaprepitant—Pruritus—Estropipate—osteoporosis	0.000949	0.000972	CcSEcCtD
Fosaprepitant—Discomfort—Zoledronate—osteoporosis	0.000948	0.000971	CcSEcCtD
Fosaprepitant—Asthenia—Alendronate—osteoporosis	0.000947	0.00097	CcSEcCtD
Fosaprepitant—Hypersensitivity—Ibandronate—osteoporosis	0.000947	0.00097	CcSEcCtD
Fosaprepitant—Cough—Conjugated Estrogens—osteoporosis	0.000947	0.00097	CcSEcCtD
Fosaprepitant—Dyspnoea—Risedronate—osteoporosis	0.000945	0.000968	CcSEcCtD
Fosaprepitant—Erythema multiforme—Estradiol—osteoporosis	0.000944	0.000967	CcSEcCtD
Fosaprepitant—Hypotension—Pamidronate—osteoporosis	0.000941	0.000964	CcSEcCtD
Fosaprepitant—Dry mouth—Zoledronate—osteoporosis	0.000939	0.000961	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000938	0.000961	CcSEcCtD
Fosaprepitant—Fatigue—Ethinyl Estradiol—osteoporosis	0.000937	0.00096	CcSEcCtD
Fosaprepitant—Pruritus—Alendronate—osteoporosis	0.000934	0.000957	CcSEcCtD
Fosaprepitant—Dyspepsia—Risedronate—osteoporosis	0.000933	0.000955	CcSEcCtD
Fosaprepitant—Eye disorder—Estradiol—osteoporosis	0.000933	0.000955	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—CALCR—osteoporosis	0.000931	0.0392	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—PTH1R—osteoporosis	0.000931	0.0392	CbGpPWpGaD
Fosaprepitant—Tinnitus—Estradiol—osteoporosis	0.00093	0.000953	CcSEcCtD
Fosaprepitant—Constipation—Ethinyl Estradiol—osteoporosis	0.000929	0.000952	CcSEcCtD
Fosaprepitant—Hypersensitivity—Calcitriol—osteoporosis	0.000927	0.00095	CcSEcCtD
Fosaprepitant—Cardiac disorder—Estradiol—osteoporosis	0.000926	0.000949	CcSEcCtD
Fosaprepitant—Flushing—Estradiol—osteoporosis	0.000926	0.000949	CcSEcCtD
Fosaprepitant—Chest pain—Conjugated Estrogens—osteoporosis	0.000924	0.000947	CcSEcCtD
Fosaprepitant—Asthenia—Ibandronate—osteoporosis	0.000922	0.000945	CcSEcCtD
Fosaprepitant—Anxiety—Conjugated Estrogens—osteoporosis	0.000921	0.000943	CcSEcCtD
Fosaprepitant—Nausea—Etidronic acid—osteoporosis	0.000921	0.000943	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Zoledronate—osteoporosis	0.00092	0.000942	CcSEcCtD
Fosaprepitant—Oedema—Zoledronate—osteoporosis	0.00092	0.000942	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000918	0.00094	CcSEcCtD
Fosaprepitant—Diarrhoea—Estropipate—osteoporosis	0.000917	0.00094	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Risedronate—osteoporosis	0.000915	0.000937	CcSEcCtD
Fosaprepitant—Infection—Zoledronate—osteoporosis	0.000914	0.000936	CcSEcCtD
Fosaprepitant—Fatigue—Risedronate—osteoporosis	0.000913	0.000936	CcSEcCtD
Fosaprepitant—Insomnia—Pamidronate—osteoporosis	0.000911	0.000933	CcSEcCtD
Fosaprepitant—Pruritus—Ibandronate—osteoporosis	0.00091	0.000932	CcSEcCtD
Fosaprepitant—Pain—Risedronate—osteoporosis	0.000906	0.000928	CcSEcCtD
Fosaprepitant—Constipation—Risedronate—osteoporosis	0.000906	0.000928	CcSEcCtD
Fosaprepitant—Angiopathy—Estradiol—osteoporosis	0.000905	0.000927	CcSEcCtD
Fosaprepitant—Shock—Zoledronate—osteoporosis	0.000905	0.000927	CcSEcCtD
Fosaprepitant—Diarrhoea—Alendronate—osteoporosis	0.000903	0.000925	CcSEcCtD
Fosaprepitant—Asthenia—Calcitriol—osteoporosis	0.000903	0.000925	CcSEcCtD
Fosaprepitant—Nervous system disorder—Zoledronate—osteoporosis	0.000902	0.000924	CcSEcCtD
Fosaprepitant—Immune system disorder—Estradiol—osteoporosis	0.000901	0.000923	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Estradiol—osteoporosis	0.000899	0.000921	CcSEcCtD
Fosaprepitant—Dyspnoea—Pamidronate—osteoporosis	0.000898	0.00092	CcSEcCtD
Fosaprepitant—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000896	0.000917	CcSEcCtD
Fosaprepitant—Somnolence—Pamidronate—osteoporosis	0.000895	0.000917	CcSEcCtD
Fosaprepitant—Skin disorder—Zoledronate—osteoporosis	0.000894	0.000915	CcSEcCtD
Fosaprepitant—Pruritus—Calcitriol—osteoporosis	0.00089	0.000912	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Zoledronate—osteoporosis	0.000889	0.000911	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000889	0.00091	CcSEcCtD
Fosaprepitant—Diarrhoea—Raloxifene—osteoporosis	0.000889	0.00091	CcSEcCtD
Fosaprepitant—Dyspepsia—Pamidronate—osteoporosis	0.000887	0.000908	CcSEcCtD
Fosaprepitant—Dizziness—Estropipate—osteoporosis	0.000887	0.000908	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000886	0.000907	CcSEcCtD
Fosaprepitant—Oedema—Conjugated Estrogens—osteoporosis	0.000886	0.000907	CcSEcCtD
Fosaprepitant—Infection—Conjugated Estrogens—osteoporosis	0.00088	0.000902	CcSEcCtD
Fosaprepitant—Diarrhoea—Ibandronate—osteoporosis	0.00088	0.000901	CcSEcCtD
Fosaprepitant—Decreased appetite—Pamidronate—osteoporosis	0.000876	0.000897	CcSEcCtD
Fosaprepitant—Mental disorder—Estradiol—osteoporosis	0.000874	0.000896	CcSEcCtD
Fosaprepitant—Dizziness—Alendronate—osteoporosis	0.000873	0.000894	CcSEcCtD
Fosaprepitant—Shock—Conjugated Estrogens—osteoporosis	0.000872	0.000893	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00087	0.000891	CcSEcCtD
Fosaprepitant—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000869	0.00089	CcSEcCtD
Fosaprepitant—Erythema—Estradiol—osteoporosis	0.000869	0.00089	CcSEcCtD
Fosaprepitant—Malnutrition—Estradiol—osteoporosis	0.000869	0.00089	CcSEcCtD
Fosaprepitant—Fatigue—Pamidronate—osteoporosis	0.000868	0.00089	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Risedronate—osteoporosis	0.000866	0.000887	CcSEcCtD
Fosaprepitant—Urticaria—Ethinyl Estradiol—osteoporosis	0.000863	0.000884	CcSEcCtD
Fosaprepitant—Pain—Pamidronate—osteoporosis	0.000861	0.000882	CcSEcCtD
Fosaprepitant—Constipation—Pamidronate—osteoporosis	0.000861	0.000882	CcSEcCtD
Fosaprepitant—Diarrhoea—Calcitriol—osteoporosis	0.000861	0.000882	CcSEcCtD
Fosaprepitant—Skin disorder—Conjugated Estrogens—osteoporosis	0.00086	0.000881	CcSEcCtD
Fosaprepitant—Hypotension—Zoledronate—osteoporosis	0.00086	0.000881	CcSEcCtD
Fosaprepitant—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000859	0.00088	CcSEcCtD
Fosaprepitant—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000859	0.00088	CcSEcCtD
Fosaprepitant—Dizziness—Raloxifene—osteoporosis	0.000859	0.00088	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000856	0.000877	CcSEcCtD
Fosaprepitant—Flatulence—Estradiol—osteoporosis	0.000856	0.000877	CcSEcCtD
Fosaprepitant—Vomiting—Estropipate—osteoporosis	0.000852	0.000873	CcSEcCtD
Fosaprepitant—Dysgeusia—Estradiol—osteoporosis	0.000851	0.000871	CcSEcCtD
Fosaprepitant—Dizziness—Ibandronate—osteoporosis	0.00085	0.000871	CcSEcCtD
Fosaprepitant—Rash—Estropipate—osteoporosis	0.000845	0.000866	CcSEcCtD
Fosaprepitant—Dermatitis—Estropipate—osteoporosis	0.000845	0.000865	CcSEcCtD
Fosaprepitant—Urticaria—Risedronate—osteoporosis	0.000842	0.000862	CcSEcCtD
Fosaprepitant—Headache—Estropipate—osteoporosis	0.00084	0.00086	CcSEcCtD
Fosaprepitant—Vomiting—Alendronate—osteoporosis	0.00084	0.00086	CcSEcCtD
Fosaprepitant—Abdominal pain—Risedronate—osteoporosis	0.000838	0.000858	CcSEcCtD
Fosaprepitant—Body temperature increased—Risedronate—osteoporosis	0.000838	0.000858	CcSEcCtD
Fosaprepitant—Muscle spasms—Estradiol—osteoporosis	0.000835	0.000856	CcSEcCtD
Fosaprepitant—Rash—Alendronate—osteoporosis	0.000833	0.000853	CcSEcCtD
Fosaprepitant—Insomnia—Zoledronate—osteoporosis	0.000832	0.000852	CcSEcCtD
Fosaprepitant—Dermatitis—Alendronate—osteoporosis	0.000832	0.000852	CcSEcCtD
Fosaprepitant—Feeling abnormal—Pamidronate—osteoporosis	0.00083	0.00085	CcSEcCtD
Fosaprepitant—Hypotension—Conjugated Estrogens—osteoporosis	0.000828	0.000848	CcSEcCtD
Fosaprepitant—Headache—Alendronate—osteoporosis	0.000827	0.000847	CcSEcCtD
Fosaprepitant—Vomiting—Raloxifene—osteoporosis	0.000826	0.000846	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Pamidronate—osteoporosis	0.000824	0.000844	CcSEcCtD
Fosaprepitant—Dyspnoea—Zoledronate—osteoporosis	0.00082	0.00084	CcSEcCtD
Fosaprepitant—Rash—Raloxifene—osteoporosis	0.000819	0.000839	CcSEcCtD
Fosaprepitant—Dermatitis—Raloxifene—osteoporosis	0.000818	0.000838	CcSEcCtD
Fosaprepitant—Somnolence—Zoledronate—osteoporosis	0.000818	0.000838	CcSEcCtD
Fosaprepitant—Vomiting—Ibandronate—osteoporosis	0.000817	0.000837	CcSEcCtD
Fosaprepitant—Headache—Raloxifene—osteoporosis	0.000814	0.000833	CcSEcCtD
Fosaprepitant—Rash—Ibandronate—osteoporosis	0.000811	0.00083	CcSEcCtD
Fosaprepitant—Dermatitis—Ibandronate—osteoporosis	0.00081	0.00083	CcSEcCtD
Fosaprepitant—Dyspepsia—Zoledronate—osteoporosis	0.00081	0.00083	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Estradiol—osteoporosis	0.000806	0.000826	CcSEcCtD
Fosaprepitant—Headache—Ibandronate—osteoporosis	0.000805	0.000825	CcSEcCtD
Fosaprepitant—Insomnia—Conjugated Estrogens—osteoporosis	0.000801	0.000821	CcSEcCtD
Fosaprepitant—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000801	0.00082	CcSEcCtD
Fosaprepitant—Vomiting—Calcitriol—osteoporosis	0.0008	0.00082	CcSEcCtD
Fosaprepitant—Decreased appetite—Zoledronate—osteoporosis	0.0008	0.000819	CcSEcCtD
Fosaprepitant—Nausea—Estropipate—osteoporosis	0.000796	0.000816	CcSEcCtD
Fosaprepitant—Abdominal pain—Pamidronate—osteoporosis	0.000796	0.000816	CcSEcCtD
Fosaprepitant—Body temperature increased—Pamidronate—osteoporosis	0.000796	0.000816	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000794	0.000814	CcSEcCtD
Fosaprepitant—Angioedema—Estradiol—osteoporosis	0.000794	0.000813	CcSEcCtD
Fosaprepitant—Rash—Calcitriol—osteoporosis	0.000794	0.000813	CcSEcCtD
Fosaprepitant—Fatigue—Zoledronate—osteoporosis	0.000793	0.000813	CcSEcCtD
Fosaprepitant—Dermatitis—Calcitriol—osteoporosis	0.000793	0.000812	CcSEcCtD
Fosaprepitant—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00079	0.000809	CcSEcCtD
Fosaprepitant—Headache—Calcitriol—osteoporosis	0.000788	0.000808	CcSEcCtD
Fosaprepitant—Somnolence—Conjugated Estrogens—osteoporosis	0.000788	0.000807	CcSEcCtD
Fosaprepitant—Constipation—Zoledronate—osteoporosis	0.000787	0.000806	CcSEcCtD
Fosaprepitant—Pain—Zoledronate—osteoporosis	0.000787	0.000806	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000784	0.033	CbGpPWpGaD
Fosaprepitant—Nausea—Alendronate—osteoporosis	0.000784	0.000803	CcSEcCtD
Fosaprepitant—Malaise—Estradiol—osteoporosis	0.000783	0.000802	CcSEcCtD
Fosaprepitant—Hypersensitivity—Risedronate—osteoporosis	0.000781	0.0008	CcSEcCtD
Fosaprepitant—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00078	0.000799	CcSEcCtD
Fosaprepitant—Asthenia—Ethinyl Estradiol—osteoporosis	0.00078	0.000799	CcSEcCtD
Fosaprepitant—Syncope—Estradiol—osteoporosis	0.000779	0.000798	CcSEcCtD
Fosaprepitant—Nausea—Raloxifene—osteoporosis	0.000771	0.00079	CcSEcCtD
Fosaprepitant—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00077	0.000789	CcSEcCtD
Fosaprepitant—Pruritus—Ethinyl Estradiol—osteoporosis	0.000769	0.000788	CcSEcCtD
Fosaprepitant—Palpitations—Estradiol—osteoporosis	0.000768	0.000786	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000765	0.000783	CcSEcCtD
Fosaprepitant—Fatigue—Conjugated Estrogens—osteoporosis	0.000764	0.000782	CcSEcCtD
Fosaprepitant—Nausea—Ibandronate—osteoporosis	0.000764	0.000782	CcSEcCtD
Fosaprepitant—Loss of consciousness—Estradiol—osteoporosis	0.000764	0.000782	CcSEcCtD
Fosaprepitant—Asthenia—Risedronate—osteoporosis	0.00076	0.000779	CcSEcCtD
Fosaprepitant—Feeling abnormal—Zoledronate—osteoporosis	0.000758	0.000777	CcSEcCtD
Fosaprepitant—Cough—Estradiol—osteoporosis	0.000758	0.000777	CcSEcCtD
Fosaprepitant—Pain—Conjugated Estrogens—osteoporosis	0.000758	0.000776	CcSEcCtD
Fosaprepitant—Constipation—Conjugated Estrogens—osteoporosis	0.000758	0.000776	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Zoledronate—osteoporosis	0.000752	0.000771	CcSEcCtD
Fosaprepitant—Hypertension—Estradiol—osteoporosis	0.00075	0.000768	CcSEcCtD
Fosaprepitant—Pruritus—Risedronate—osteoporosis	0.00075	0.000768	CcSEcCtD
Fosaprepitant—Nausea—Calcitriol—osteoporosis	0.000748	0.000766	CcSEcCtD
Fosaprepitant—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000744	0.000762	CcSEcCtD
Fosaprepitant—Hypersensitivity—Pamidronate—osteoporosis	0.000742	0.00076	CcSEcCtD
Fosaprepitant—Chest pain—Estradiol—osteoporosis	0.00074	0.000758	CcSEcCtD
Fosaprepitant—Anxiety—Estradiol—osteoporosis	0.000737	0.000755	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000734	0.000752	CcSEcCtD
Fosaprepitant—Urticaria—Zoledronate—osteoporosis	0.000731	0.000749	CcSEcCtD
Fosaprepitant—Discomfort—Estradiol—osteoporosis	0.000731	0.000749	CcSEcCtD
Fosaprepitant—Abdominal pain—Zoledronate—osteoporosis	0.000727	0.000745	CcSEcCtD
Fosaprepitant—Body temperature increased—Zoledronate—osteoporosis	0.000727	0.000745	CcSEcCtD
Fosaprepitant—Diarrhoea—Risedronate—osteoporosis	0.000725	0.000743	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000724	0.000742	CcSEcCtD
Fosaprepitant—Dry mouth—Estradiol—osteoporosis	0.000723	0.000741	CcSEcCtD
Fosaprepitant—Asthenia—Pamidronate—osteoporosis	0.000723	0.00074	CcSEcCtD
Fosaprepitant—Dizziness—Ethinyl Estradiol—osteoporosis	0.000719	0.000736	CcSEcCtD
Fosaprepitant—Pruritus—Pamidronate—osteoporosis	0.000713	0.00073	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Estradiol—osteoporosis	0.000709	0.000726	CcSEcCtD
Fosaprepitant—Oedema—Estradiol—osteoporosis	0.000709	0.000726	CcSEcCtD
Fosaprepitant—Infection—Estradiol—osteoporosis	0.000704	0.000722	CcSEcCtD
Fosaprepitant—Urticaria—Conjugated Estrogens—osteoporosis	0.000704	0.000721	CcSEcCtD
Fosaprepitant—Dizziness—Risedronate—osteoporosis	0.000701	0.000718	CcSEcCtD
Fosaprepitant—Abdominal pain—Conjugated Estrogens—osteoporosis	0.0007	0.000717	CcSEcCtD
Fosaprepitant—Body temperature increased—Conjugated Estrogens—osteoporosis	0.0007	0.000717	CcSEcCtD
Fosaprepitant—Shock—Estradiol—osteoporosis	0.000698	0.000715	CcSEcCtD
Fosaprepitant—Nervous system disorder—Estradiol—osteoporosis	0.000695	0.000712	CcSEcCtD
Fosaprepitant—Vomiting—Ethinyl Estradiol—osteoporosis	0.000691	0.000708	CcSEcCtD
Fosaprepitant—Diarrhoea—Pamidronate—osteoporosis	0.000689	0.000706	CcSEcCtD
Fosaprepitant—Skin disorder—Estradiol—osteoporosis	0.000689	0.000705	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Estradiol—osteoporosis	0.000685	0.000702	CcSEcCtD
Fosaprepitant—Rash—Ethinyl Estradiol—osteoporosis	0.000685	0.000702	CcSEcCtD
Fosaprepitant—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000685	0.000701	CcSEcCtD
Fosaprepitant—Headache—Ethinyl Estradiol—osteoporosis	0.000681	0.000697	CcSEcCtD
Fosaprepitant—Hypersensitivity—Zoledronate—osteoporosis	0.000678	0.000694	CcSEcCtD
Fosaprepitant—Vomiting—Risedronate—osteoporosis	0.000674	0.00069	CcSEcCtD
Fosaprepitant—Rash—Risedronate—osteoporosis	0.000668	0.000684	CcSEcCtD
Fosaprepitant—Dermatitis—Risedronate—osteoporosis	0.000667	0.000684	CcSEcCtD
Fosaprepitant—Dizziness—Pamidronate—osteoporosis	0.000666	0.000682	CcSEcCtD
Fosaprepitant—Headache—Risedronate—osteoporosis	0.000664	0.00068	CcSEcCtD
Fosaprepitant—Asthenia—Zoledronate—osteoporosis	0.00066	0.000676	CcSEcCtD
Fosaprepitant—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000653	0.000669	CcSEcCtD
Fosaprepitant—Pruritus—Zoledronate—osteoporosis	0.000651	0.000667	CcSEcCtD
Fosaprepitant—Nausea—Ethinyl Estradiol—osteoporosis	0.000645	0.000661	CcSEcCtD
Fosaprepitant—Insomnia—Estradiol—osteoporosis	0.000641	0.000657	CcSEcCtD
Fosaprepitant—Vomiting—Pamidronate—osteoporosis	0.00064	0.000656	CcSEcCtD
Fosaprepitant—Asthenia—Conjugated Estrogens—osteoporosis	0.000636	0.000651	CcSEcCtD
Fosaprepitant—Rash—Pamidronate—osteoporosis	0.000635	0.000651	CcSEcCtD
Fosaprepitant—Dermatitis—Pamidronate—osteoporosis	0.000634	0.00065	CcSEcCtD
Fosaprepitant—Dyspnoea—Estradiol—osteoporosis	0.000632	0.000647	CcSEcCtD
Fosaprepitant—Headache—Pamidronate—osteoporosis	0.000631	0.000646	CcSEcCtD
Fosaprepitant—Somnolence—Estradiol—osteoporosis	0.00063	0.000646	CcSEcCtD
Fosaprepitant—Diarrhoea—Zoledronate—osteoporosis	0.000629	0.000645	CcSEcCtD
Fosaprepitant—Nausea—Risedronate—osteoporosis	0.000629	0.000645	CcSEcCtD
Fosaprepitant—Pruritus—Conjugated Estrogens—osteoporosis	0.000627	0.000642	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000626	0.0263	CbGpPWpGaD
Fosaprepitant—Dyspepsia—Estradiol—osteoporosis	0.000624	0.000639	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—LEP—osteoporosis	0.000623	0.0262	CbGpPWpGaD
Fosaprepitant—Decreased appetite—Estradiol—osteoporosis	0.000616	0.000631	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Estradiol—osteoporosis	0.000612	0.000627	CcSEcCtD
Fosaprepitant—Fatigue—Estradiol—osteoporosis	0.000611	0.000626	CcSEcCtD
Fosaprepitant—Dizziness—Zoledronate—osteoporosis	0.000608	0.000623	CcSEcCtD
Fosaprepitant—Pain—Estradiol—osteoporosis	0.000606	0.000621	CcSEcCtD
Fosaprepitant—Constipation—Estradiol—osteoporosis	0.000606	0.000621	CcSEcCtD
Fosaprepitant—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000606	0.000621	CcSEcCtD
Fosaprepitant—Nausea—Pamidronate—osteoporosis	0.000598	0.000613	CcSEcCtD
Fosaprepitant—Dizziness—Conjugated Estrogens—osteoporosis	0.000586	0.0006	CcSEcCtD
Fosaprepitant—Vomiting—Zoledronate—osteoporosis	0.000585	0.000599	CcSEcCtD
Fosaprepitant—Feeling abnormal—Estradiol—osteoporosis	0.000584	0.000598	CcSEcCtD
Fosaprepitant—Rash—Zoledronate—osteoporosis	0.00058	0.000594	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Estradiol—osteoporosis	0.00058	0.000594	CcSEcCtD
Fosaprepitant—Dermatitis—Zoledronate—osteoporosis	0.00058	0.000594	CcSEcCtD
Fosaprepitant—Headache—Zoledronate—osteoporosis	0.000576	0.00059	CcSEcCtD
Fosaprepitant—Vomiting—Conjugated Estrogens—osteoporosis	0.000563	0.000577	CcSEcCtD
Fosaprepitant—Urticaria—Estradiol—osteoporosis	0.000563	0.000577	CcSEcCtD
Fosaprepitant—Body temperature increased—Estradiol—osteoporosis	0.00056	0.000574	CcSEcCtD
Fosaprepitant—Abdominal pain—Estradiol—osteoporosis	0.00056	0.000574	CcSEcCtD
Fosaprepitant—Rash—Conjugated Estrogens—osteoporosis	0.000559	0.000572	CcSEcCtD
Fosaprepitant—Dermatitis—Conjugated Estrogens—osteoporosis	0.000558	0.000572	CcSEcCtD
Fosaprepitant—Headache—Conjugated Estrogens—osteoporosis	0.000555	0.000568	CcSEcCtD
Fosaprepitant—Nausea—Zoledronate—osteoporosis	0.000546	0.00056	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—PTH1R—osteoporosis	0.000526	0.0221	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CALCR—osteoporosis	0.000526	0.0221	CbGpPWpGaD
Fosaprepitant—Nausea—Conjugated Estrogens—osteoporosis	0.000526	0.000539	CcSEcCtD
Fosaprepitant—Hypersensitivity—Estradiol—osteoporosis	0.000522	0.000535	CcSEcCtD
Fosaprepitant—Asthenia—Estradiol—osteoporosis	0.000509	0.000521	CcSEcCtD
Fosaprepitant—Pruritus—Estradiol—osteoporosis	0.000502	0.000514	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—PTH—osteoporosis	0.000489	0.0206	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Estradiol—osteoporosis	0.000485	0.000497	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CALCR—osteoporosis	0.000478	0.0201	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PTH1R—osteoporosis	0.000478	0.0201	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CNR2—osteoporosis	0.000477	0.0201	CbGpPWpGaD
Fosaprepitant—Dizziness—Estradiol—osteoporosis	0.000469	0.00048	CcSEcCtD
Fosaprepitant—Vomiting—Estradiol—osteoporosis	0.000451	0.000462	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—WNT1—osteoporosis	0.000448	0.0189	CbGpPWpGaD
Fosaprepitant—Rash—Estradiol—osteoporosis	0.000447	0.000458	CcSEcCtD
Fosaprepitant—Dermatitis—Estradiol—osteoporosis	0.000447	0.000457	CcSEcCtD
Fosaprepitant—Headache—Estradiol—osteoporosis	0.000444	0.000455	CcSEcCtD
Fosaprepitant—Nausea—Estradiol—osteoporosis	0.000421	0.000431	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—MGLL—osteoporosis	0.000418	0.0176	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000418	0.0176	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—PTHLH—osteoporosis	0.000405	0.0171	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1B—osteoporosis	0.000397	0.0167	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—MGLL—osteoporosis	0.00038	0.016	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—POMC—osteoporosis	0.000366	0.0154	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CALCA—osteoporosis	0.000357	0.015	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000323	0.0136	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000318	0.0134	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SOST—osteoporosis	0.000312	0.0131	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MYC—osteoporosis	0.000309	0.013	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TGFB1—osteoporosis	0.000309	0.013	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—osteoporosis	0.000288	0.0121	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CALCR—osteoporosis	0.000282	0.0119	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTH1R—osteoporosis	0.000282	0.0119	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PTH—osteoporosis	0.000276	0.0116	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CNR2—osteoporosis	0.000269	0.0113	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PTH—osteoporosis	0.000251	0.0106	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000245	0.0103	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CNR2—osteoporosis	0.000245	0.0103	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL6—osteoporosis	0.000233	0.00979	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000231	0.0097	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—WNT1—osteoporosis	0.00023	0.00968	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PTHLH—osteoporosis	0.000229	0.00964	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MGLL—osteoporosis	0.000224	0.00944	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LRP5—osteoporosis	0.000219	0.00921	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LRP6—osteoporosis	0.000209	0.00881	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PTHLH—osteoporosis	0.000208	0.00875	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CALCA—osteoporosis	0.000202	0.00849	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—POMC—osteoporosis	0.000187	0.00786	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000186	0.00783	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CALCA—osteoporosis	0.000183	0.00771	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TLN1—osteoporosis	0.000177	0.00744	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—P4HB—osteoporosis	0.000152	0.00642	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTH—osteoporosis	0.000148	0.00624	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RAP1A—osteoporosis	0.000146	0.00613	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CNR2—osteoporosis	0.000145	0.00608	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000144	0.00606	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADCY5—osteoporosis	0.000143	0.00604	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NFATC1—osteoporosis	0.000142	0.00598	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—DKK1—osteoporosis	0.000141	0.00594	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—WNT1—osteoporosis	0.000136	0.00572	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FGA—osteoporosis	0.000132	0.00556	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADCY5—osteoporosis	0.00013	0.00548	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTHLH—osteoporosis	0.000123	0.00517	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—BMP2—osteoporosis	0.000123	0.00517	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FGB—osteoporosis	0.00012	0.00506	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PSMA2—osteoporosis	0.000116	0.00489	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PSMA5—osteoporosis	0.000116	0.00489	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CALCA—osteoporosis	0.000108	0.00455	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—POMC—osteoporosis	0.000106	0.00444	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KL—osteoporosis	9.83e-05	0.00413	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—POMC—osteoporosis	9.58e-05	0.00403	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6R—osteoporosis	9.35e-05	0.00393	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADCY5—osteoporosis	7.7e-05	0.00324	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SPP1—osteoporosis	7.45e-05	0.00313	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IRS2—osteoporosis	6.73e-05	0.00283	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LEP—osteoporosis	6.59e-05	0.00277	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ESR1—osteoporosis	6.29e-05	0.00265	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IRS1—osteoporosis	5.88e-05	0.00247	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—POMC—osteoporosis	5.66e-05	0.00238	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6R—osteoporosis	5.52e-05	0.00232	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IGF1—osteoporosis	5.45e-05	0.00229	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6—osteoporosis	4.16e-05	0.00175	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MYC—osteoporosis	3.27e-05	0.00138	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TGFB1—osteoporosis	3.26e-05	0.00137	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6—osteoporosis	2.46e-05	0.00104	CbGpPWpGaD
